AI assistant
NEOGENOMICS INC — Director's Dealing 2022
Jun 3, 2022
32227_dirs_2022-06-02_51017591-9888-4eaa-94e6-b795b3b78817.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-06-01
Reporting Person: Sikri Vishal (President and CCO, Inivata)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-01 | Common Stock | A | 148455 | — | Acquired | 148455 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-06-01 | Stock Option (Right to Buy) | $8.42 | A | 319112 | Acquired | 2029-06-01 | Common Stock (319112.0) | Direct |
Footnotes
F1: On June 1, 2022, Mr. Sikri was granted 89,073 restricted stock awards. These awards vest ratably over the first two anniversary dates of the grant date.
F2: On June 1, 2022, Mr. Sikri was granted 59,382 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
F3: On June 1, 2022, Mr. Sikri was granted 193,799 stock options. These options vest ratably over the first two anniversary dates of the grant date.
F4: On June 1, 2022, Mr. Sikri was granted 125,313 stock options. These options vest ratably over the first four anniversary dates of the grant date.